The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-Chlorophenyl)-4,5-dihydro-4-(4-methoxyphenyl)-2Hindazol-3-ol ID: ALA2272765
PubChem CID: 71570656
Max Phase: Preclinical
Molecular Formula: C20H17ClN2O2
Molecular Weight: 352.82
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C2CC(c3ccc(Cl)cc3)=Cc3n[nH]c(O)c32)cc1
Standard InChI: InChI=1S/C20H17ClN2O2/c1-25-16-8-4-13(5-9-16)17-10-14(12-2-6-15(21)7-3-12)11-18-19(17)20(24)23-22-18/h2-9,11,17H,10H2,1H3,(H2,22,23,24)
Standard InChI Key: RPKDFBKUMHXXST-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
26.7349 -20.6913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9288 -20.5637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8012 -19.7535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5288 -19.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7420 -18.5938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5294 -18.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1077 -18.9631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8987 -19.7505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1072 -19.9637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0735 -19.3853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1636 -18.0155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3721 -18.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7979 -17.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0069 -16.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7984 -16.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3768 -17.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4286 -16.2845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6513 -16.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8992 -18.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1083 -17.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8998 -17.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4781 -18.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2650 -19.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4735 -19.3284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2655 -18.1147 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 2 0
4 9 1 0
3 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 1 0
14 17 1 0
5 11 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
22 25 1 0
7 19 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.82Molecular Weight (Monoisotopic): 352.0979AlogP: 4.85#Rotatable Bonds: 3Polar Surface Area: 58.14Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.22CX Basic pKa: 2.80CX LogP: 4.51CX LogD: 3.11Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.71Np Likeness Score: -0.18
References 1. Shakil NA, Singh MK, Sathiyendiran M, Kumar J, Padaria JC.. (2013) Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives., 59 [PMID:23229055 ] [10.1016/j.ejmech.2012.10.038 ]